2,5-Dimethoxy-4-methylphenylcyclopropylamine (DMCPA) is a lesser-known
psychedelic drug
Psychedelics are a subclass of hallucinogenic drugs whose primary effect is to trigger non-ordinary mental states (known as psychedelic experiences or "trips") and a perceived "expansion of consciousness". Also referred to as classic halluc ...
and a
substituted amphetamine
Substituted amphetamines, or simply amphetamines, are a chemical class, class of compounds based upon the amphetamine structure; it includes all derivative (chemistry), derivative compounds which are formed by replacing, or substitution reacti ...
and
phenylcyclopropylamine. DMCPA was first synthesized by
Alexander Shulgin. In his book ''
PiHKAL
''PiHKAL: A Chemical Love Story'' is a book by Alexander Shulgin and Ann Shulgin published in 1991. The subject of the work is Psychoactive drug, psychoactive phenethylamine Derivative (chemistry), chemical derivatives, notably those that act ...
'', the dosage range is listed as 15–20 mg and the duration is listed as 4–8 hours.
[DMCPA Entry in ''PiHKAL''](_blank)
/ref> DMCPA produces open-eye visuals, anorexia, and psychedelic dreams.
Pharmacology
Very little data exists about the pharmacological properties, metabolism, and toxicity of DMCPA.
Legal status
United Kingdom
This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.
See also
* Phenethylamine
* Psychedelics, dissociatives and deliriants
* Tranylcypromine
References
{{DEFAULTSORT:Dimethoxy-4-methylphenylcyclopropylamine, 2,5-
DOx (psychedelics)
Phenylcyclopropylamines
Psychedelic phenethylamines